Germany: Life Sciences, Biotechnology & Nanotechnology

A European Patent Office Technical Board of Appeal decision examines when algorithmic features in medical monitoring systems can support inventive step claims. The case centers on a blood glucose variability measurement system where the technical effect depends critically on the observation period, raising fundamental questions about claim scope and technical contribution.

The chemical and pharmaceutical industry in Germany is undergoing a profound shift. Competitive pressure from Asia continues to intensify, regulatory demands are rising, and long-established innovation models are proving less effective under current market conditions.

Not only does the Act partially legalise recreational cannabis, it also signifies important changes in the area of medical cannabis.